Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuning Anticancer Activity and Antimicrobial Response of ZnO Nanoparticles Through Halogenosilane Surface Modification.

International journal of molecular sciences·2026
Same author

Immune (dys)function in obsessive-compulsive disorder.

Brain, behavior, and immunity·2026
Same author

Integrating green chemistry into SPION development: a theranostic study on prostate cell models.

Nanoscale·2026
Same author

Fe/<sup>57</sup>Fe-Metallacarboranes with Radiosensitizing Potential in Breast Cancer Cell Models: Comparative Study Between High- (<sup>60</sup>Co) and Low-Energy (<sup>57</sup>Co) Gamma Radiation Sources.

Pharmaceutics·2026
Same author

HF-Sensor: A non-invasive biosensor system for heart failure diagnosis and monitoring at the point-of-care.

Biosensors & bioelectronics·2026
Same author

Portuguese Consensus Guidelines for the Diagnosis and Treatment of Myasthenia Gravis.

Acta medica portuguesa·2025

Related Experiment Video

Updated: Mar 25, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K

Nano- and micro-based systems for immunotolerance induction in multiple sclerosis.

Liliana R Pires1, Fernanda Marques2,3, João Carlos Sousa2,3

  • 1a International Iberian Nanotechnology Laboratory , Braga , Portugal.

Human Vaccines & Immunotherapeutics
|February 19, 2016
PubMed
Summary
This summary is machine-generated.

New microneedle patch technology offers a novel approach to treating multiple sclerosis (MS) by restoring immune balance. This method uses antigen-specific interactions to potentially overcome limitations of current immunosuppressive therapies for MS.

Keywords:
immunomodulationmicroneedlesmultiple sclerosisnanoparticlestolerance

More Related Videos

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

937
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

11.3K

Related Experiment Videos

Last Updated: Mar 25, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

937
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

11.3K

Area of Science:

  • Neuroimmunology
  • Biotechnology
  • Nanotechnology

Background:

  • Multiple sclerosis (MS) is a debilitating autoimmune neurodegenerative disease affecting over 2.5 million people globally.
  • Current MS treatments, primarily immunosuppressants and immunomodulators, carry risks of opportunistic infections.
  • Existing therapies do not fully restore immune homeostasis, highlighting the need for innovative solutions.

Purpose of the Study:

  • To explore the potential of nano and micro-technologies for treating multiple sclerosis (MS).
  • To propose microneedle patches as a novel, minimally invasive therapeutic delivery system for MS.
  • To investigate antigen-specific interactions for restoring immune tolerance in MS.

Main Methods:

  • Review and commentary on the application of nano and micro-technologies in MS therapy.
  • Discussion of microneedle patch technology for antigen delivery.
  • Focus on antigen-specific interactions to modulate the immune response in MS.

Main Results:

  • Nano and micro-technologies present innovative therapeutic avenues for MS.
  • Microneedle patches offer a promising minimally invasive approach for antigen delivery.
  • Antigen-specific strategies hold potential for restoring immune homeostasis in MS.

Conclusions:

  • Microneedle patches represent a novel therapeutic strategy for multiple sclerosis (MS).
  • This approach aims to restore immunotolerance through targeted antigen delivery.
  • Further research into microneedle technology could lead to improved MS management with reduced infection risk.